Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033

Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033



The Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors Such As increasing prevalence of ophthalmic disorders and cost efficiency provided by CDMOs are driving the market growth

Several important elements that support the expansion and significance of the ophthalmic drugs contract manufacturing market in the pharmaceutical industry. One of the main causes is the rising incidence of ocular conditions like age-related macular degeneration (AMD), glaucoma, cataracts, and dry eye syndrome. Pharmaceutical companies are looking for effective drug manufacturing solutions as the aging population increases and lifestyle habit changes and there is an increasing need for effective pharmaceuticals to treat and maintain these eye problems.

Additionally, by outsourcing manufacturing to the CDMOs, enables pharmaceutical businesses to concentrate on their core capabilities, such as research and marketing. This strategic partnership shortens the time of ophthalmic medications to reach the market and thereby streamlining drug development process. Modern technologies and strong quality control procedures used by CDMOs guarantee the creation of high-quality medicines that satisfy market needs and regulatory requirements.

Economical effectiveness one of the major factor driving these companies to adopt CDMO services as it takes a significant financial investment in staff, facilities, and equipment to develop new pharmaceutical goods. Companies want to reduce the overall the cost and labour costs through outsourcing to the CDMOs.

Since CDMOs already have the necessary resources and knowledge, producing drugs, it turns to be a less expensive and involves fewer risks for investors.

Complex regulatory framework may pose as challenges in the ophthalmic drugs contract manufacturing market

Noncompliance with regulatory standards and poor pharmaceutical quality can have severe consequences for a business and its brand reputation. Therefore, adherence to regulatory rules is crucial in the pharmaceutical industry. Contract development and manufacturing organizations (CDMOs) face challenges in ensuring compliance with varying regulatory requirements across different regions and countries, particularly in the ophthalmic drug contract manufacturing industry.

As pharmaceutical companies outsource drug manufacturing to specialized CDMOs focusing on ophthalmic products, they encounter a complex web of diverse regulatory frameworks. Each region has its distinct guidelines, standards, and procedures governing various aspects of ophthalmic drug manufacturing and distribution. This includes quality control, safety assessments, and labelling, packaging, and distribution practices. Complying with these unique requirements demands a meticulous approach from contract manufacturers to ensure full compliance with the specific regulations of the markets they serve. This aspect could potentially limit the expansion of the pharmaceutical CDMO market in the coming years.

What Questions Should You Ask before Buying a Market Research Report?
  • How is the ophthalmic drugs contract manufacturing market evolving?
  • What is driving and restraining the ophthalmic drugs contract manufacturing market?
  • How will each ophthalmic drugs contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each ophthalmic drugs contract manufacturing submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading ophthalmic drugs contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of ophthalmic drugs contract manufacturing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the ophthalmic drugs contract manufacturing market?
  • Where is the ophthalmic drugs contract manufacturing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?
  • You need to discover how this will impact the Ophthalmic Drugs Contract Manufacturing market today, and over the next 10 years:
  • Our 334-page report provides 122 tables, 174 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • This report tells you TODAY how the ophthalmic drugs contract manufacturing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

    Forecasts to 2033 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising ophthalmic drugs contract manufacturing prices and recent developments.
  • This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

    Segments Covered in the Report

    Product Type
  • API
  • FDFs
  • Primary Packaging Type
  • Ampoules & Vials
  • Glass & Plastic Bottles
  • Ointment Tubes
  • Others
  • Scale of Manufacturing
  • Preclinical
  • Clinical
  • Commercial
  • Company Size
  • Small Sized
  • Mid Sized
  • Large Sized
  • Indication
  • Age-Related Macular Degeneration
  • Glaucoma
  • Uveitis
  • Dry Eye Disease
  • Others
  • In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

    North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • Spain
  • UK
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • MEA
  • GCC Countries
  • South Africa
  • Rest of MEA
  • The report also includes profiles and for some of the leading companies in the Ophthalmic Drugs Contract Manufacturing Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

    Leading companies and the potential for market growth
  • Abbvie Inc.
  • Catalent Inc.
  • Eurofins Scientific
  • Glenmark Pharmaceuticals
  • Jubilant HollisterStier LLC
  • Laboratorios Salvat, S.A.
  • Lonza
  • Merck KGaA
  • Pillar5 Pharma
  • Recipharm
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Unither Pharmaceuticals
  • Overall world revenue for Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033 in terms of value the market will surpass US$3,683.4 million in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

    How will the Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033 report help you?

    In summary, our 330+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033 Market, with forecasts for mode of delivery, clinical trial phase, therapeutic area, end users and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Ophthalmic Drugs Contract Manufacturing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

    Information found nowhere else

    With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

    Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..

    The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.


    1 Report Overview
    1.1 Objectives of the Study
    1.2 Introduction to Ophthalmic Drugs Contract Manufacturing Market
    1.3 What This Report Delivers
    1.4 Why You Should Read This Report
    1.5 Key Questions Answered by This Analytical Report
    1.6 Who is This Report for?
    1.7 Methodology
    1.7.1 Market Definitions
    1.7.2 Market Evaluation & Forecasting Methodology
    1.7.3 Data Validation
    1.7.3.1 Primary Research
    1.7.3.2 Secondary Research
    1.8 Frequently Asked Questions (FAQs)
    1.9 Associated Visiongain Reports
    1.10 About Visiongain
    2 Executive Summary
    3 Market Overview
    3.1 Key Findings
    3.2 Market Dynamics
    3.2.1 Market Driving Factors
    3.2.1.1 High cost of in-house drug development is likely to propel the market growth
    3.2.1.2 Growing prevalence of ophthalmic disorders
    3.2.1.3 Reduced overall cost and time to the market
    3.2.1.4 Ease of Supply Chain Issues and Bandwidth to Focus on Core Competencies
    3.2.2 Market Restraining Factors
    3.2.2.1 Varying regulatory requirements across regions
    3.2.2.2 Introduction of Serialization
    3.2.3 Market Opportunities
    3.2.3.1 Growth in Emerging Markets
    3.2.3.2 Scalability and flexible production capacity
    3.2.3.3 Specialized Services for Niche Markets and Late-Stage Customization
    3.2.3.4 Process Improvement with better AI, e-Platforms, real time and remote tracing
    3.3 COVID-19 Impact Analysis
    3.4 Porter’s Five Forces Analysis
    3.4.1 Bargaining Power of Suppliers (Medium)
    3.4.2 Bargaining Power of Buyers (Medium to High)
    3.4.3 Competitive Rivalry (High)
    3.4.4 Threat from Substitutes (Medium)
    3.4.5 Threat of New Entrants (High)
    3.5 PEST Analysis
    3.5.1 Political
    3.5.2 Economical
    3.5.3 Social
    3.5.4 Technological
    4 Ophthalmic Drugs Contract Manufacturing Market Analysis by Product Type
    4.1 Key Findings
    4.2 Product Type Segment: Market Attractiveness Index
    4.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    4.4 APIs
    4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    4.4.2 Market Share by Region, 2023 & 2033 (%)
    4.5 FDFs
    4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    4.5.2 Market Share by Region, 2023 & 2033 (%)
    4.5.3 FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    5 Ophthalmic Drugs Contract Manufacturing Market Analysis by Primary Packaging
    5.1 Key Findings
    5.2 Primary Packaging Segment: Market Attractiveness Index
    5.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging
    5.4 Ampoules & Vials
    5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    5.4.2 Market Share by Region, 2023 & 2033 (%)
    5.5 Glass & Plastic Bottles
    5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    5.5.2 Market Share by Region, 2023 & 2033 (%)
    5.6 Ointment Tubes
    5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    5.6.2 Market Share by Region, 2023 & 2033 (%)
    5.7 Others
    5.7.1 Market Size by Region, 2023-2033 (US$ Million)
    5.7.2 Market Share by Region, 2023 & 2033 (%)
    6 Ophthalmic Drugs Contract Manufacturing Market Analysis by Scale of Manufacturing
    6.1 Key Findings
    6.2 Scale of Manufacturing Segment: Market Attractiveness Index
    6.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing
    6.4 Preclinical
    6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    6.4.2 Market Share by Region, 2023 & 2033 (%)
    6.5 Clinical
    6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    6.5.2 Market Share by Region, 2023 & 2033 (%)
    6.6 Commercial
    6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    6.6.2 Market Share by Region, 2023 & 2033 (%)
    7 Ophthalmic Drugs Contract Manufacturing Market Analysis by Company Size
    7.1 Key Findings
    7.2 Company Size Segment: Market Attractiveness Index
    7.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size
    7.4 Small Size
    7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    7.4.2 Market Share by Region, 2023 & 2033 (%)
    7.5 Mid-Sized
    7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    7.5.2 Market Share by Region, 2023 & 2033 (%)
    7.6 Large Sized
    7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    7.6.2 Market Share by Region, 2023 & 2033 (%)
    8 Ophthalmic Drugs Contract Manufacturing Market Analysis by Indication
    8.1 Key Findings
    8.2 Indication Segment: Market Attractiveness Index
    8.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication
    8.4 Age-Related Macular Degeneration
    8.4.1 Market Size by Region, 2023-2033 (US$ Million)
    8.4.2 Market Share by Region, 2023 & 2033 (%)
    8.5 Glaucoma
    8.5.1 Market Size by Region, 2023-2033 (US$ Million)
    8.5.2 Market Share by Region, 2023 & 2033 (%)
    8.6 Uveitis
    8.6.1 Market Size by Region, 2023-2033 (US$ Million)
    8.6.2 Market Share by Region, 2023 & 2033 (%)
    8.7 Dry Eye Disease
    8.7.1 Market Size by Region, 2023-2033 (US$ Million)
    8.7.2 Market Share by Region, 2023 & 2033 (%)
    8.8 Others
    8.8.1 Market Size by Region, 2023-2033 (US$ Million)
    8.8.2 Market Share by Region, 2023 & 2033 (%)
    9 Ophthalmic Dug Contract Manufacturing Market Analysis by Region
    9.1 Key Findings
    9.2 Regional Market Size Estimation and Forecast
    10 North America Ophthalmic Drugs Contract Manufacturing Market Analysis
    10.1 Key Findings
    10.2 North America Ophthalmic Drug Contract Manufacturing Market Attractiveness Index
    10.3 North America Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
    10.4 North America Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country
    10.5 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    10.5.1 North America FDFs Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    10.6 North America Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging
    10.7 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing
    10.8 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size
    10.9 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication
    10.10 U.S. Ophthalmic Drugs Contract Manufacturing Market Analysis
    10.11 Canada Ophthalmic Drugs Contract Manufacturing Market Analysis
    11 Europe Ophthalmic Drugs Contract Manufacturing Market Analysis
    11.1 Key Findings
    11.2 Europe Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index
    11.3 Europe Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
    11.4 Europe Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country
    11.5 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    11.5.1 Europe FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    11.6 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging
    11.7 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing
    11.8 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size
    11.9 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication
    11.10 Germany Ophthalmic Drugs Contract Manufacturing Market Analysis
    11.11 UK Ophthalmic Drugs Contract Manufacturing Market Analysis
    11.12 France Ophthalmic Drugs Contract Manufacturing Market Analysis
    11.13 Italy Ophthalmic Drugs Contract Manufacturing Market Analysis
    11.14 Spain Ophthalmic Drugs Contract Manufacturing Market Analysis
    11.15 Rest of Europe Ophthalmic Drugs Contract Manufacturing Market Analysis
    12 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Analysis
    12.1 Key Findings
    12.2 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index
    12.3 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
    12.4 Asia Pacific Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country
    12.5 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    12.5.1 Asia Pacific FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    12.6 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging
    12.7 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing
    12.8 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size
    12.9 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication
    12.10 Japan Ophthalmic Drugs Contract Manufacturing Market Analysis
    12.11 China Ophthalmic Drugs Contract Manufacturing Market Analysis
    12.12 India Ophthalmic Drugs Contract Manufacturing Market Analysis
    12.13 Australia Ophthalmic Drugs Contract Manufacturing Market Analysis
    12.14 South Korea Ophthalmic Drugs Contract Manufacturing Market Analysis
    12.15 Rest of Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Analysis
    13 Latin America Ophthalmic Drugs Contract Manufacturing Market Analysis
    13.1 Key Findings
    13.2 Latin America Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index
    13.3 Latin America Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
    13.4 Latin America Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country
    13.5 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    13.5.1 Latin America FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    13.6 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging
    13.7 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing
    13.8 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size
    13.9 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication
    13.10 Brazil Ophthalmic Drugs Contract Manufacturing Market Analysis
    13.11 Mexico Ophthalmic Drugs Contract Manufacturing Market Analysis
    13.12 Rest of Latin America Ophthalmic Drugs Contract Manufacturing Market Analysis
    14 MEA Ophthalmic Drugs Contract Manufacturing Market Analysis
    14.1 Key Findings
    14.2 MEA Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index
    14.3 MEA Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
    14.4 MEA Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country
    14.5 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    14.5.1 MEA FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
    14.6 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging
    14.7 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing
    14.8 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size
    14.9 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication
    14.10 GCC Ophthalmic Drugs Contract Manufacturing Market Analysis
    14.11 South Africa Ophthalmic Drugs Contract Manufacturing Market Analysis
    14.12 Rest of MEA Ophthalmic drug contract manufacturing Market Analysis
    15 Company Profiles
    15.1 Competitive Landscape, 2022
    15.2 Strategic Outlook
    15.3 Lonza
    15.3.1 Company Snapshot
    15.3.2 Company Overview
    15.3.3 Financial Analysis
    15.3.3.1 Net Revenue, 2018-2022
    15.3.3.2 R&D, 2018-2022
    15.3.4 Services Offered
    15.3.5 Strategic Outlook
    15.4 Recipharm
    15.4.1 Company Snapshot
    15.4.2 Company Overview
    15.4.3 Financial Analysis
    15.4.3.1 Net Revenue, 2018-2022
    15.4.4 Services Offered
    15.4.5 Strategic Outlook
    15.5 Catalent Inc.
    15.5.1 Company Snapshot
    15.5.2 Company Overview
    15.5.3 Financial Analysis
    15.5.3.1 Net Revenue, 2018-2022
    15.5.3.2 R&D, 2018-2022
    15.5.3.3 Regional Market Shares, 2022
    15.5.4 Services Offered
    15.5.5 Strategic Outlook
    15.6 Eurofins Scientific
    15.6.1 Company Snapshot
    15.6.2 Company Overview
    15.6.3 Financial Analysis
    15.6.3.1 Net Revenue, 2018-2022
    15.6.3.2 Regional Market Shares, 2022
    15.6.4 Services Offered
    15.6.5 Strategic Outlook
    15.7 Thermo Fisher Scientific Inc.
    15.7.1 Company Snapshot
    15.7.2 Company Overview
    15.7.3 Financial Analysis
    15.7.3.1 Net Revenue, 2018-2022
    15.7.3.2 Regional Market Shares, 2022
    15.7.4 Services Offered
    15.7.5 Strategic Outlook
    15.8 Unither Pharmaceuticals
    15.8.1 Company Snapshot
    15.8.2 Company Overview
    15.8.3 Services Offering
    15.8.4 Strategic Outlook
    15.9 Laboratorios Salvat, S.A.
    15.9.1 Company Snapshot
    15.9.2 Company Overview
    15.9.3 Services Offered
    15.9.4 Strategic Outlook
    15.10 Siegfried Holding AG
    15.10.1 Company Snapshot
    15.10.2 Company Overview
    15.10.3 Financial Analysis
    15.10.3.1 Net Revenue, 2018-2022
    15.10.3.2 R&D, 2018-2022
    15.10.4 Services Offered
    15.10.5 Strategic Outlook
    15.11 Pillar5 Pharma
    15.11.1 Company Snapshot
    15.11.2 Company Overview
    15.11.3 Service Offering
    15.11.4 Strategic Outlook
    15.12 Abbvie Inc.
    15.12.1 Company Snapshot
    15.12.2 Company Overview
    15.12.3 Service Offerings
    15.12.4 Strategic Outlook
    15.13 Jubilant HollisterStier LLC
    15.13.1 Company Snapshot
    15.13.2 Company Overview
    15.13.3 Service Offerings
    15.13.4 Strategic Outlook
    15.14 Glenmark Pharmaceuticals
    15.14.1 Company Snapshot
    15.14.2 Company Overview
    15.14.3 Financial Analysis
    15.14.3.1 Net Revenue, 2018-2022
    15.14.3.2 R&D, 2021-2022
    15.14.4 Product Benchmarking
    15.15 Merck KGaA
    15.15.1 Company Snapshot
    15.15.2 Company Overview
    15.15.3 Financial Analysis
    15.15.3.1 Net Revenue, 2018-2022
    15.15.3.2 R&D, 2018-2022
    15.15.3.3 Regional Market Shares, 2022
    15.15.4 Service Offerings
    15.15.5 Strategic Outlook
    16 Conclusion and Recommendations
    16.1 Concluding Remarks from Visiongain
    16.2 Recommendations for Market Players

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings